Ropes & Gray was founded in 1865 in Boston. It has since expanded globally to 11 offices in three continents. In the United States the firm has offices in Boston, Chicago, New York, San Francisco, Silicon Valley and Washington DC.
Focusses / specialisms
The firm is best known for its work in the United States for financial services regulatory, private equity and registered funds’ work.
The firm’s Boston office is market leader in the region in banking, capital markets and M&A.
In banking the firm represents borrowers and lenders in acquisition financing, refinancing and general corporate financing.
The capital markets practice has experience on both the issuer and underwriter side in debt, equity, derivatives and structured finance and securitizations matters. In the debt capital markets, the firm works on investment grade and high yield bond offerings. On the equity capital markets side, the team has experience in IPOs, share offerings, share buybacks and follow on offerings. In derivatives, the team works on hedges and regulatory CFTC compliance. Structured finance and securitizations work includes ABS’, CLOs and whole business securitizations.
In the investment funds practice the firm primarily works with private equity funds, hedge funds and registered funds in fund formation, investments and fund raising.
The private equity and M&A practices advise clients on the buy and sell side in acquisitions, mergers and joint ventures.
The restructuring and insolvency team represents creditors, debtors and trustees in out of court restructurings and Chapter 11 proceedings.
Key clients
Key clients for the firm include Bain Capital, Golden Gate Capital, Genstar Capital, IQVIA, Surgery Partners, Michaels Stores, Morgan Stanley, Goldman Sachs, Beam Therapeutics, Wright Medical Group, Domino’s Pizza, Planet Fitness, Dunkin’ Brands Group, BlackRock, Paine Schwartz & Partners, CCMP Capital, Ashmore Investment Advisors, Athyrium Capital Management, PIMCO, Baring Private Equity Asia, TPG Capital, Audax Group, Deutsche Bank Securities, PJT Partners, Veeam Software, the Baupost Group, Elliott Management and Marathon Asset Management.
Research period review: 30th edition (2019/2020)
In the most recent research period, the banking team largely represented private equity firms on the borrower side in acquisition finance matters.
The debt capital markets team worked on a mix of investment grade and high yield bond offerings, many of which were connected to acquisition financing.
The equity capital markets team worked on a lot of IPOs and follow on offerings, especially in the life sciences industry.
Most of the derivatives work was related to regulatory CFTC compliance.
In structured finance and securitizations, most of the work was related to ABS’ and whole business securitizations.
In investment funds the firm continued assisting with fund formations and investments for leading private equity, hedge and registered funds.
In M&A and private equity, the teams acted on both the buy and sell side in high value acquisitions.
The restructuring and insolvency team acted for many creditors in Chapter 11 proceedings and out of court restructurings. Firm wide, technology, healthcare and life sciences were big industries.
Regarding lateral moves the banking team brought over partners Andrea Hwang and Leonard Klingbaum from Willkie Farr & Gallagher. Partner Sunil Savkar left to join Debevoise & Plimpton. In private equity, the firm brought over partners Martin Ruhaak, Scott Abramowitz and Carolyn Vardi from Katten Muchin, Kramer Levin and White & Case, respectively. New York partner Cristine Pirro Schwarzman moved to Ropes & Gray from Kirkland & Ellis.
Deal highlights: 30th edition (2019/2020)
ArcLight Capital Partners Fund VII
Avantor NYSE IPO
Bain Capital financing for acquisition of US Renal Care
Clarivate Analytics $4.2 billion acquisition of Churchill Capital
Dunkin’ $1.7 billion ABS
IQVIA €720 million 4.875% bond issueLine Corp / Yahoo Japan merger
PG&E Chapter 11 restructuring
